Author

V. V. Ptushkin

Observed names: V.V. Ptushkin, Vadim V. Ptushkin

Institution: Botkin Hospital

Observed institutions: Botkin Hospital, City Clinical Hospital

ORCID: 0000-0002-9368-6050

Observed ORCID: 0000-0002-9368-6050

OpenAlex ID: A5022236929

Treatment patterns, outcomes and long-term toxicity among patients with Hodgkin’s lymphoma in real world: results of a hospital based registry

2016 · E. A. Nikitin, N. N. Sharkunov, et al. · Oncohematology · 3

Characteristics and 5-year outcomes in patients with chronic lymphocytic leukemia receiving ibrutinib (a real-world study)

2026 · Umida P. Ergasheva, Elizaveta P. Panchenko, et al. · Terapevticheskii arkhiv · 2

Domestic experience of prevention and treatment of skin toxicity in patients with metastatic colorectal cancer receiving inhibitors of EGFR: the example of using of panitumumab

2015 · S. E. Varlamova, E. V. Orlova, et al. · Malignant tumours · 2

How to use ibrutinib

2017 · Е. А. Nikitin, V. I. Vorobiev, et al. · Oncohematology · 1

First-line antitumor therapy for diffuse large B-cell lymphoma: results of the Moscow oncology registry analysis from 2022 to 2025

2026 · Marat A. Mingalimov, E. A. Baryakh, et al. · Oncohematology

Is Venetoclax Effective in Combination with Standard Therapy for Relapses of Diffuse Large B-Cell Lymphoma?

2026 · L.S. Butaev, V.A. Zherebtsova, et al. · A I Burnasyan Federal Medical Biophysical Center Clinical Bulletin

Efficacy and Safety of Glofitamab Therapy in Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma: A United Russian Experience Based on the Compassionate Use Program

2026 · Liudmila Valerevna Fedorova, N. B. Mikhailova, et al. · Clinical oncohematology

Works count: 7

Citation count: 8

H-index: 2

I10-index: